Clinuvel Pharmaceuticals

(ASX) CUV

Current Price$9.12

Market Cap$469.83M

Since IPO (2001)+891%

5 Year-68%

1 Year-19%

1 Month-8%

Clinuvel Pharmaceuticals Financials at a Glance

Market Cap

$469.83M

Revenue (TTM)

$187.33M

Net Income (TTM)

$71.32M

EPS (TTM)

$0.64

P/E Ratio

14.35

Dividend

$0.05

Beta (Volatility)

0.14 (Low)

Dividend

$0.05

Beta (Volatility)

0.14 (Low)

Price

$9.12

Volume

Open

$9.30

Price

$9.12

Volume

Open

$9.30

Previous Close

$9.12

Daily Range

$9.05 - $9.30

52-Week Range

$8.57 - $14.00

Dividend

$0.05

Beta (Volatility)

0.14 (Low)

Price

$9.12

Volume

Open

$9.30

Previous Close

$9.12

Daily Range

$9.05 - $9.30

52-Week Range

$8.57 - $14.00

CUV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Clinuvel Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

CEO

Lachlan Hay

Website

www.clinuvel.com

Headquarters

Melbourne, VIC 3000, AU

CUV Financials

Key Financial Metrics (TTM)

Gross Margin

64%

Operating Margin

39%

Net Income Margin

34%

Return on Equity

14%

Return on Capital

15%

Return on Assets

12%

Earnings Yield

6.97%

Dividend Yield

0.54%

Payout Ratio

7.70%

Stock Overview

Market Cap

$469.83M

Shares Outstanding

50.41M

Volume

Avg. Volume

112.35K

Financials (TTM)

Gross Profit

$79.14M

Operating Income

$45.73M

EBITDA

$57.20M

Operating Cash Flow

$41.10M

Capital Expenditure

$298.57K

Free Cash Flow

$40.80M

Cash & ST Invst.

$224.11M

Total Debt

$528.53K

Clinuvel Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$36.93M

+14.5%

Gross Profit

$20.75M

+22.6%

Gross Margin

56.19%

N/A

Market Cap

$469.83M

N/A

Market Cap/Employee

$29.36M

N/A

Employees

N/A

Net Income

$10.44M

-4.5%

EBITDA

$11.46M

-20.8%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$232.66M

+34.2%

Accounts Receivable

$16.58M

+26.8%

Inventory

$8.41M

-33.0%

Long Term Debt

$34.50K

-95.2%

Short Term Debt

$306.60K

-13.8%

Return on Assets

12.07%

N/A

Return on Invested Capital

15.06%

N/A

Free Cash Flow

$12.38M

-41.3%

Operating Cash Flow

$12.52M

-52.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RAC.AXRace Oncology Limited

RAC.AXRace Oncology Limited$2.61-1.14%

OCA.AXOceania Healthcare Limited

OCA.AXOceania Healthcare Limited$0.60+4.35%

CGS.AXCogstate Limited

CGS.AXCogstate Limited$2.48-0.40%

HLS.AXHealius Limited

HLS.AXHealius Limited$0.51-1.94%

ACL.AXAustralian Clinical Labs Limited

ACL.AXAustralian Clinical Labs Limited$1.89-1.05%

EBR.AXEBR Systems, Inc.

EBR.AXEBR Systems, Inc.$0.63+2.44%

PGC.AXParagon Care Limited

PGC.AXParagon Care Limited$0.15-3.23%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$94.48-0.00%

NOKNokia

NOKNokia$12.91+0.04%

AMZNAmazon

AMZNAmazon$265.06+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.10+0.04%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.63+0.10%

MARAMara Holdings

MARAMara Holdings$11.99+0.12%

FFord Motor Company

FFord Motor Company$12.08-0.01%

Questions About CUV

What is the current price of Clinuvel Pharmaceuticals?

Clinuvel Pharmaceuticals is trading at A$9.12 per share.

What is the 52-week range for Clinuvel Pharmaceuticals?

Over the past 52 weeks, Clinuvel Pharmaceuticals has traded between A$8.57 and A$14.00.

How much debt does Clinuvel Pharmaceuticals have?

As of the most recent reporting period, Clinuvel Pharmaceuticals reported total debt of $528,528.

How much cash does Clinuvel Pharmaceuticals have on hand?

Clinuvel Pharmaceuticals reported $28.02M in cash and cash equivalents in its most recent financial results.

What is Clinuvel Pharmaceuticals’s dividend yield?

Clinuvel Pharmaceuticals currently has a dividend yield of 0.54%.

Clinuvel Pharmaceuticals

Clinuvel Pharmaceuticals Financials at a Glance

CUV News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Clinuvel Pharmaceuticals

CUV Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Clinuvel Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CUV

What is the current price of Clinuvel Pharmaceuticals?

What is the 52-week range for Clinuvel Pharmaceuticals?

How much debt does Clinuvel Pharmaceuticals have?

How much cash does Clinuvel Pharmaceuticals have on hand?

What is Clinuvel Pharmaceuticals’s dividend yield?

Premium Investing Services